JP2011512364A5 - - Google Patents

Download PDF

Info

Publication number
JP2011512364A5
JP2011512364A5 JP2010547006A JP2010547006A JP2011512364A5 JP 2011512364 A5 JP2011512364 A5 JP 2011512364A5 JP 2010547006 A JP2010547006 A JP 2010547006A JP 2010547006 A JP2010547006 A JP 2010547006A JP 2011512364 A5 JP2011512364 A5 JP 2011512364A5
Authority
JP
Japan
Prior art keywords
dendrimer
amino acid
dendrimer according
polypeptide
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010547006A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011512364A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2009/000201 external-priority patent/WO2009103127A1/en
Publication of JP2011512364A publication Critical patent/JP2011512364A/ja
Publication of JP2011512364A5 publication Critical patent/JP2011512364A5/ja
Pending legal-status Critical Current

Links

JP2010547006A 2008-02-22 2009-02-23 治療用ペプチド Pending JP2011512364A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2008900848A AU2008900848A0 (en) 2008-02-22 Therapeutic peptides
PCT/AU2009/000201 WO2009103127A1 (en) 2008-02-22 2009-02-23 Therapeutic peptides

Publications (2)

Publication Number Publication Date
JP2011512364A JP2011512364A (ja) 2011-04-21
JP2011512364A5 true JP2011512364A5 (cg-RX-API-DMAC10.html) 2013-05-02

Family

ID=40985007

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010547006A Pending JP2011512364A (ja) 2008-02-22 2009-02-23 治療用ペプチド

Country Status (5)

Country Link
US (1) US20110105408A1 (cg-RX-API-DMAC10.html)
EP (1) EP2254901A4 (cg-RX-API-DMAC10.html)
JP (1) JP2011512364A (cg-RX-API-DMAC10.html)
AU (1) AU2009217237A1 (cg-RX-API-DMAC10.html)
WO (1) WO2009103127A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010215086A1 (en) * 2009-02-23 2011-09-08 Inter-K Pty Limited Inhibition of multiple cell activation pathways
EP3228714B1 (en) 2010-12-14 2019-03-27 Stichting Katholieke Universiteit Chemiluminescence-based haemostasis assay
CN104271590B (zh) * 2012-01-24 2018-06-05 Inter-K私人有限公司 用于癌治疗的肽剂

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177263A (en) * 1972-02-28 1979-12-04 Research Corporation Anti-animal tumor method
US5962643A (en) * 1991-07-11 1999-10-05 The Regents Of The University Of California Integrin β subunit and uses thereof
US6514745B1 (en) * 1993-07-19 2003-02-04 The Regents Of The University Of California Oncoprotein protein kinase
US5807746A (en) * 1994-06-13 1998-09-15 Vanderbilt University Method for importing biologically active molecules into cells
US6495518B1 (en) * 1994-06-13 2002-12-17 Vanderbilt University Method for importing biologically active molecules into cells
US5877282A (en) * 1996-09-20 1999-03-02 Bristol-Myers Squibb Company Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof
US6495514B1 (en) * 1998-01-21 2002-12-17 Mercer University Method for reducing inflammation and inducing an analgesic effect and compounds thereof
US6248558B1 (en) * 1998-03-31 2001-06-19 Vanderbilt University Sequence and method for genetic engineering of proteins with cell membrane translocating activity
JP4439120B2 (ja) * 1998-10-16 2010-03-24 大塚製薬株式会社 新生血管特異的ペプチド
ATE385503T1 (de) * 1999-06-28 2008-02-15 Inter K Pty Ltd Verfahren zur modulierung von integrin- vermittelter zellaktivitaet und hierfuer geeignete reagenzien
US6312956B1 (en) * 1999-10-01 2001-11-06 Vanderbilt University Nuclear targeted peptide nucleic acid oligomer
US6471968B1 (en) * 2000-05-12 2002-10-29 Regents Of The University Of Michigan Multifunctional nanodevice platform
AUPR230500A0 (en) * 2000-12-22 2001-01-25 University Of Newcastle Research Associates Limited, The A method of modulating map kinase mediated cellular activity and agents useful in same
EP1684795A4 (en) * 2003-10-17 2009-07-29 Inter K Pty Ltd METHODS AND AGENTS FOR THE TREATMENT OF CANCER
US20060257359A1 (en) * 2005-02-28 2006-11-16 Cedric Francois Modifying macrophage phenotype for treatment of disease
US20060204443A1 (en) * 2005-03-11 2006-09-14 The Government Of The Usa As Represented By The Secretary Of The Dept. Of Health & Human Services Methods for tumor treatment using dendrimer conjugates

Similar Documents

Publication Publication Date Title
EP2583976A3 (en) Peptide vaccines with SEQ ID NO: 210, 196, 202, 213, 214, 214 or 223 for cancers expressing tumor-associated antigens
NZ603732A (en) Cell-penetrating peptides and uses therof
MX2012008998A (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX2012008999A (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX2012009000A (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
IN2014KN01713A (cg-RX-API-DMAC10.html)
IN2014KN01716A (cg-RX-API-DMAC10.html)
IN2014KN01714A (cg-RX-API-DMAC10.html)
NZ602943A (en) Modified binding proteins inhibiting the vegf-a receptor interaction
IN2012DN02981A (cg-RX-API-DMAC10.html)
MX2009010965A (es) Péptidos de tem8 y vacunas que los contienen.
NZ602845A (en) Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof
IN2014DN09963A (cg-RX-API-DMAC10.html)
EP2030984A4 (en) DERIVED FROM SPARC CANCER EXHAUSTANTEPEPTIDE AND PHARMACEUTICALS CONTAINING THEREOF
WO2011135222A3 (fr) Utilisation de peptides comme transporteurs destines a l'internalisation de molecules d'interet dans des cellules cibles
MX2009007261A (es) Vacuna de peptido foxp3.
MX2010005816A (es) Epítopos de péptido de stat3.
MX365599B (es) Moleculas de transporte especificas de proteoglicano c4s.
CA2819463C (en) Tomm34 peptides and vaccines including the same
EP3868778A3 (en) Cdc45l peptides and vaccines including the same
MX2011008917A (es) Peptidos vangl1 y vacunas que incluyen los mismos.
NZ592461A (en) Rab6kifl/kif20a epitope peptide and vaccines containing the same
CN114375333B (zh) 包含赖氨酰氧化酶的前肽的组合物及其用途
NZ603379A (en) Ect2 peptides and vaccines including the same
SG10201408245WA (en) Tmem22 peptides and vaccines including the same